Clinical Trials May Provide Access to New Technology for Treating GERD
Clinical Trials May Provide Access to New Technology for Treating GERD
Published on April 25 by
There have been recent advances in the treatment of gastroesophageal reflux disease (GERD). The FDA has approved Stretta, EsophyX, and the LINX Reflux Management System to address the leaky valve that causes reflux, or the lower esophageal sphincter (LES). Even though these are all FDA approved, insurance may not cover these procedures, despite data showing […]